WallStreetZenWallStreetZen

NASDAQ: TLX
Telix Pharmaceuticals Ltd Stock Ownership - Who owns Telix Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Telix Pharmaceuticals Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Darren Charlton SmithCFO2026-09-072,071$9.66
$20.00kBuy
Christian BehrenbruchMD Group CEO2026-04-2933,435$14.87
$497.18kBuy
Christian BehrenbruchMD Group CEO2026-04-2834,500$14.48
$499.56kBuy

1 of 1

TLX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TLX insiders and whales buy or sell their stock.

TLX Shareholders

What type of owners hold Telix Pharmaceuticals Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Christian Behrenbruch6.18%20,996,941$199.68MInsider
Mark Alexander Nelson1.07%3,628,750$34.51MInsider
Jann Elizabeth Skinner0.18%595,000$5.66MInsider
David Norman Cade0.11%373,133$3.55MInsider
Darren Charlton Smith0.00%13,992$133.06kInsider
Marie Elizabeth McDonald0.00%3,719$35.37kInsider
Darren Joel Patti0.00%804$7.65kInsider
Fmr LLC0.00%561$5.34kInstitution
Fidlty0.00%561$5.34kInstitution
Lazard0.00%284$2.70kInstitution

1 of 3

TLX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TLX0.00%7.54%Net BuyingNet Buying
TARS0.11%39.11%Net SellingNet Selling
AMLX0.10%50.21%Net SellingNet Selling
DYN0.10%20.12%Net SellingNet Selling
IRON0.11%65.28%Net SellingNet Selling
View Top Biotech Stocks

Telix Pharmaceuticals Stock Ownership FAQ

Who owns Telix Pharmaceuticals?

Telix Pharmaceuticals (NASDAQ: TLX) is owned by 0.00% institutional shareholders, 7.54% Telix Pharmaceuticals insiders, and 92.46% retail investors. Christian Behrenbruch is the largest individual Telix Pharmaceuticals shareholder, owning 21.00M shares representing 6.18% of the company. Christian Behrenbruch's Telix Pharmaceuticals shares are currently valued at $199.68M.

If you're new to stock investing, here's how to buy Telix Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.